Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Thrombocytopenia

• A Randomized, Double-blind, Placebo-controlled, and Multi-center Clinical Study of CM313 in the Treatment of Immune Thrombocytopenia
• Teriflunomide for Steroid-resistant/Relapse Immune Thrombocytopenia
• The Combination of Teriflunomide and Danazol for Steroid-resistant/Relapse Immune Thrombocytopenia
• Teriflunomide Plus High-dose Dexamethasone as First-line Treatment in Newly Diagnosed Primary Immune Thrombocytopenia
• Anti-CD38 Antibody Treating Pediatric Primary Immune Thrombocytopenia (ITP)
• The Safety and Tolerability of STSA-1301 Subcutaneous Injection in Healthy Subjects
• The Efficacy and Safety of Hetrombopag as Secondary Prevention to Chemotherapy-induced Thrombocytopenia in Patients With Gynecologic Malignancies
• A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Pediatric Primary Immune Thrombocytopenia (ITP)
• Use of Vitamin D as An Adjuvant Treatment in Children With Chronic Idiopathic Thrombocytopenic Purpura
• Antiplatelet Therapy for AIS Patients With Thrombocytopenia
• Anti-CD38 Antibody Treating Evans Syndrome
• A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia
• High-dose Dexamethasone Plus Hetrombopag vs High-dose Dexamethasone Alone as Frontline Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Prospective, Multicenter, Randomized Trial
• Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Solid Tumors.
• Immune Thrombocytopenia Management in Adults
• Low-dose Baricitinib Plus Danazol for Steroid-resistant/Relapse Immune Thrombocytopenia
• Evaluating the Efficacy and Safety of QL0911 in Chemotherapy- Induced Thrombocytopenia
• A Randomized, Double-Blind Phase 2 Study of VLX-1005 Versus Placebo in Suspected Heparin Induced Thrombocytopenia
• Human Mass Balance of [14C]HMPL-523 in Healthy Adult Male Chinese Subjects
• Avatrombopag vs. Placebo for CIT in GI Malignancies
• An Open-label Study of ALPN-303 in Subjects With Autoimmune Cytopenias
• TPO-RAs Combining Anti-CD 20 Monoclonal Antibody Versus TPO-RAs in the Management of Pediatric Primary Immune Thrombocytopenia (ITP)
• A Prospective, One-arm and Open Clinical Study of CM313 in the Treatment of Immune Thrombocytopenia
• Tacrolimus Plus Glucocorticoid for Severe Thrombocytopenia in SS
• Extension Study of Herombopag for Pediatric Patients With Chronic Immune Thrombocytopenia
• Tacrolimus for Thrombocytopenia in SS
• Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP)
• A Study of Efficacy and Safety of Ianalumab Versus Placebo in Addition to Eltrombopag in Primary Immune Thrombocytopenia Patients Who Failed Steroids
• Canakinumab for the Prevention of Progression to Cancer in Patients With Clonal Cytopenias of Unknown Significance, IMPACT Study
• IVIg Plus Low Dose rhTPO for ITP in Pregnancy
• Efficacy and Safety of QL0911 in Adult Patients With Chronic Primary Immune Thrombocytopenia: A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase III Trial
• Evaluate the Efficacy and Safety of Various Treatment Schemes for Severe Fever With Thrombocytopenia Syndrome(SFTS)
• The Investigate Efficacy and Safety Evaluation of Bortezomib in Patients With Relapsed/Refractory Immune Thrombocytopenia
• A Randomized Trial Comparing Optimized rhTPO Treatment With Eltrombopag Treatment in Pre-treated ITP Pts
• Herombopag Olamine in the Treatment of Thrombocytopenia After Chemotherapy
• A Clinical Trial to Assess Safety and Efficacy of Daratumumab in the Treatment of Primary Immune Thrombocytopenia
• Evaluating the Efficacy and Safety of QL0911 in the Prevention of Chemotherapy- Induced Thrombocytopenia
• Evaluation of the Effect in Platelet Count of Atorvastatin and N-acetyl Cysteine
• Short-course High-dose Prednisone and Dexamethasone in Children With ITP
• Two Regimens of IVIG in the Treatment of Newly Diagnosed ITP in Children
• Extension Study (Extended Access) of Syk-inhibition Using Fostamatinib to Treat Posttransplant Immune-mediated Cytopenias
• A Phase II Study Using Fostamatinib to Treat Post-Hematopoietic Stem Cell Transplant Immune-Mediated Cytopenias
• The Combination of Terbutaline and Danazol as the Treatment of Corticosteroid-resistant/Relapse Immune Thrombocytopenia
• Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS)
• The Combination of Tacrolimus and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia
• Combined Steroid and Cyclosporin as First-line Treatment in Adults With Primary Immune Thrombocytopenia
• Baricitinib for Steroid-resistant/Relapse Immune Thrombocytopenia
• Efficacy and Safety of Herombopag in Patients With Thrombocytopenia Before Hepatectomy
• Intravenous Immunoglobulin (IVIG, Bioven) Efficacy and Safety in Chronic Primary Immune Thrombocytopenia (ITP) in Adults
• A Multicenter Randomized Open-label Study of Chidamide Plus HD-DEX Versus HD-DEX in ITP
• Efficacy and Safety of rhTPO's Prophylactic Treatment of CTIT in Patients With High Risk of Cardiac Injury
• Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in Adult Essential Thrombocythemia
• A Clinical Study of Hetrombopag Olamine Tablets for Thrombocytopenia Induced by Chemotherapy in Advanced Breast Cancer
• Hetrombopag for Lower-risk MDS With Thrombocytopenia: a Prospective，Open-label, Single-arm Study.
• Efficacy and Safety of Avatrombopag for Treating TCP in HBV-ACLF Patients Receiving ALSS Treatment
• Zanubrutinib and Eltrombopag as Second-line Treatment in Adults With Primary Immune Thrombocytopenia
• The Combination of Zanubrutinib and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia
• Evaluation of Avatrombopag for the Treatment of Thrombocytopenia in Japanese Adults With Chronic ITP
• Platelet Augmentation Using C. Papaya Leaf Extract in Live Donor Liver Transplantation
• The Combination of Sitagliptin and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia
• A Clinical Study of Herombopag in Tumors-associated Thrombocytopenia
• Efficacy and Safety of Subcutaneous Belimumab or Placebo in Addition of Rituximab in Persistent or Chronic Immune Thrombocytopenia
• The Combination of Prednisone and Recombinant Human Thrombopoietin for Treatment of Immune Thrombocytopenia in Pregnancy
• Herombopag + rhTPO in Severe Immune Thrombocytopenia
• Romiplostim Plus Dexamethasone vs Dexamethasone in Patients With Newly Diagnosed Primary Immune Thrombocytopenia
• A Phase I Study of the Co-administration of VLX-1005 and Argatroban in Healthy Human Subjects
• Efficacy and Safety of TPO Receptor Agonists in the Treatment of Elderly ITP Patients
• Efficacy and Safety of Iguratimod in the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia
• The Combination of Iguratimod and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia
• A Study of Zanubrutinib in Patients With ITP
• A Clinical Study of Hetrombopag Olamine Tablets in Adults Receiving 21-day Cycles of Chemotherapy for Solid Tumours, Who Are Delayed for at Least 1 Week From Their Scheduled Cycle Because of Chemotherapy-induced Thrombocytopenia
• An Exploratory Study of Herombopag for Thrombocytopenia Induced by Chemotherapy Combined With Immunotherapy in NSCLC
• Herombopag for Chemotherapy-induced Thrombocytopenia
• A Study to Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Immune Thrombocytopenia
• Avatrombopag for Chemotherapy-induced Thrombocytopenia
• Effects of Recombinant Human Thrombopoietin on Platelet Levels in ICU Patients
• A Prospective, One-arm and Open Clinical Study of Zanubrutinib in the Treatment of Immune Thrombocytopenia
• Safety and Efficacy of Zanubrutinib in the Treatment of Antiphospholipid Syndrome With Secondary Thrombocytopenia
• A Phase Ib Clinical Study for rhTPO in the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease
• Clinical Study on the Efficacy and Safety of Hetropapa Ethanolamine Tablets in the Treatment of Thrombocytopenia Caused by Concurrent Radiotherapy and Chemotherapy in Cervical Cancer
• AZA Combined With NAC for PIT After HSCT
• A Study of Orelabrutinib in Patients With ITP
• A Study of Enasidenib in People With Clonal Cytopenia of Undetermined Significance
• Basket Study to Assess Efficacy, Safety and PK of Iptacopan (LNP023) in Autoimmune Benign Hematological Disorders
• Open-Label Study to Evaluate the Safety and Efficacy of Avatrombopag and Remission Rates in Adults With ITP of ≤6 Months
• COVID-19 ThromboprophylaXIs Study of Novel FXIa Inhibitor EP-7041 in ICU Patients
• Ivosidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH1
• Phase III Study on HMPL-523 for Treatment of ITP
• Hetrombopag for Low/Intermediate-1 Risk MDS With Thrombocytopenia
• A Multicenter Randomized Open-label Study of Diammonium Glycyrrhizinate Enteric-coated Capsule Plus DXM Versus DXM in Treatment of ITP
• A Clinical Trial of the Orelabrutinib in the Management of Refractory ITP
• Avatrombopag in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies
• IgIV Plus Prednisone vs High-dose Dexamethasone for ITP
• Phase II Trial of Romiplostim for Thrombocytopenia Induced by Lomustine at First Progression of MGMT Promoter-meth Glioblastoma
• Study of Avatrombopag for Temozolomide-induced Thrombocytopenia in Glioma (APATIT-G)
• Eltrombopag Plus Diacerein vs Eltrombopag in Adult ITP
• Eltrombopag Combined With Low-dose Rituximab in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies
• Efficacy of Avatrombopag in Thrombocytopenic Patients With Chronic Liver Disease Undergoing an Elective Procedure
• ASPirin in Immune thRombocytopenia Patients With Cardiovascular disEase
• Avatrombopag in Patients With End-stage Liver Disease and Thrombocytopenia
• Efficacy and Safety of Avatrombopag in Cancer Patients With Thrombocytopenia
• Avatrombopag in Primary Immune Thrombocytopenia (ITP) in Adults
• Danazol for Treatment of Cytopenias in Patients With Cirrhosis
• Avatrombopaq In Patients With Cirrhosis
• Immunomodulation With Eltrombopag in ITP
• Avatrombopag for the Primary Prevention of Thrombocytopenia Induced by Cytarabine-based Chemotherapy in Patients With Lymphoma
• The Combination of Tacrolimus and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia
• Post IVIG Medication in Children With Immune Thrombocytopenia
• Hetrombopag for Pediatric Patients With Chronic Immune Thrombocytopenia
• Using Romiplostim to Treat Low Platelet Counts During Chemotherapy in People With Lymphoma
• A Phase 2a Study Evaluating BIVV020 in Adults With Persistent/Chronic Immune Thrombocytopenia (ITP)
• Open-label Study Measuring Safety and Treatment Satisfaction in Adult Subjects With Chronic Immune Thrombocytopenia (ITP) After Switching to Avatrombopag From Eltrombopag or Romiplostim
• A Study of ATRA in the Treatment of ITP
• Avatrombopag on the Treatment of Thrombocytopenia Induced by Chemotherapy of Malignant Tumors
• Eltrombopag for Chemotherapy-induced Thrombocytopenia
• A Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)
• Romiplostim, Rituximab and Dexamethasone as Frontline Treatment for Immune Thrombocytopenia
• Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)
• LD-FUD for Highly Aggressive Gastric Cancer
• Fostamatinib as a Single Agent or in Combination With Ruxolitinib for Treatment of Patients With Myelofibrosis With Severe Thrombocytopenia
• Fixed Low-dose Eltrombopag and rhTPO for Immune Thrombocytopenia (FLOWER)
• Eltrombopag Combining Rituximab Versus Eltrombopag in the Management of Primary Immune Thrombocytopenia (ITP) in Adults
• Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects With Immune Thrombocytopenia for ≥6 Months
• Eltrombopag Plus rhTPO Versus Eltrombopag for ITP During the COVID-19 Pandemic (ELABORATE-19)
• The Combination of Terbutaline and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia
• TPO-Mimetic Use in Children for Hemotopoietic Failure
• Avatrombopag for Thrombocytopenia in People With Cancer
• Efficacy and Safety of Romiplostim Versus Eltrombopag in the Treatment of Thrombocytopenia in Patients With Wiskott-Aldrich Syndrome
• The Combination of High-dose Dexamethasone and Acetylcysteine as the Treatment of Newly-diagnosed ITP
• A Study to Assess Efficacy and Safety of Eltrombopag in Combination With a Short Course of Dexamethasone in Patients With Newly Diagnosed ITP
• A Randomized Trial of rhTPO Versus Placebo for Low/Intermediate-1 Risk MDS With Thrombocytopenia
• Avatrombopag for the Treatment of Thrombocytopenia After Donor Hematopoietic Stem Cell Transplant
• Phase II Trial of Romiplostim With Danazol in Patients With Eltrombopag-resistant Immune Thrombocytopenia
• A Study of TAK-079 in Adults With Persistent/Chronic Primary Immune Thrombocytopenia
• Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in Childhood and Adolescent Essential Thrombocythemia
• A Study to Assess the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)
• The Combination of ATRA and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia
• A Study to Evaluate the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)
• Eltrombopag in Chronic ITP
• AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
• A Multicenter Randomized Study of Vitamin D Combined With HD-DXM Versus HD-DXM for the Treatment of ITP
• Evaluating the Efficacy and Safety of Different Human Thrombopoietin (rhTPO) Regimens in the Treatment of Patients With Primary Immune Thrombocytopenia (ITP)
• Single-dose Anti-CD20 Antibody With Bortezomib for Relapsed Refractory Autoimmune Hemolytic Anemia
• Study of Oral SKI-O-703, SYK Inhibitor, in Patients With Persistent and Chronic Immune Thrombocytopenia (ITP)
• A Phase 2 Study to Evaluate the Safety and Efficacy of KZR-616 in Patients With AIHA and ITP
• Glycyrrhetinic Acid Combined With Dexamethasone in Management of Newly Diagnosed ITP
• Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Subjects With Malignancy.
• Efficacy and Safety of Ixazomib and Dexamethasone Refractory Autoimmune Cytopenia
• The Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMPL-523 in Immune Thrombocytopenia Patients
• Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children
• Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer
• A Clinical Trial of the Low Dose Chidamide in the Management of Refractory ITP
• Safety and Efficacy of Eltrombopag Plus Pulsed Dexamethasone for Subjects With Idiopathic Thrombocytopenic Purpura
• Comparison of Interleukin-11 and rhTPO for Recurrent Colorectal Cancer Patients With Thrombocytopenia
• XIENCE 28 USA Study
• Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study to Evaluate Safety and Efficacy of Danaparoid vs Argatroban
• A Pediatric Trial Using Tranexamic Acid in Thrombocytopenia
• Evolution of Thromboelastography During Tranexamic Acid Treatment
• Efficacy and Safety of rhTPO and Eltrombopag in Patients With Primary Immune Thrombocytopenia (ITP)
• A Prospective, Open, Multicenter Clinical Trial of Eltrombopag Combined With Diacerein in Eltrombopag-inefficient or Relapsed ITP
• Safety and Efficacy of Abatacept for Treating Chronic Cytopenia in Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) Haploinsufficiency
• Eltrombopag Used in Thrombocytopenia After Comsolidation Therapy in AML
• Atorvastatin in Management of Newly Diagnosed ITP
• Study of Sirolimus in CTD-TP in China
• to Evaluate the Efficacy and Safety of Eltrombopag for Thrombocytopenia With Chronic HBV Infection
• Perioperative Eltrombopag in Patients With Inherited Thrombocytopenia
• High-dose Use of rhTPO in CIT Patients
• A Study to Evaluate Different Intervals Between Dosing and Feeding on the Pharmacokinetics
• Efficacy and Safety of Apixaban in the Treatment of Heparin Induced Thrombocytopenia (HIT)
• Proof-of-Concept: A Pilot, Randomized, Double-Blind Study of Oseltamivir Versus Placebo for Immune Thrombocytopenia
• Eltrombopag vs. rhTPO to Increase Platelet Level After HSCT
• Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation
• Recombinant Human Thrombopoietin(rhTPO) in Pregnancy With Immune Thrombocytopenia
• Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Active Non-Hematological Cancers
• The Combination of Atorvastatin, Acetylcysteine and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia
• Rituximab Combining Bortezomib Versus Rituximab in Management of ITP
• A Study of PRN1008 in Adult Patients With Immune Thrombocytopenia (ITP)
• Prolonged Isolated Thrombocytopenia After Allo-SCT : N-acetyl-L-cysteine (NAC) Versus Supportive Therapy
• XIENCE 28 Global Study
• Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer
• Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
• The Combination of Low-dose Rituximab and ATRA as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia
• Allogeneic Stem Cell Transplantation for Multiple Myeloma and Myelofibrosis
• A First in HumanTrial to Evaluate The Safety, Tolerability, And Pharmacokinetics Of PF-06755347
• A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple- Dose BIVV009 in Participants With Chronic Immune Thrombocytopenia (ITP)
• The Study of Different Dose Rituximab in the Treatment of ITP
• Decitabine Combining Dexamethasone Versus Dexamethasone in Management of ITP
• Effect of NAC on the Hematopoietic Reconstitution After Haploidentical Hematopoietic Stem Cell Transplantation
• Reposition of Second Line Treatment in Chronic Immune Thrombocytopenia
• The Efficacy and Safety of Huaiqihuang Granule in Children With Chronic Primary Immune Thrombocytopenia
• H. Pylori Eradication for Moderate ITP
• Effects of Helicobacter Pylori Eradication in Children With Chronic Immune Thrombocytopenic Purpura
• The Effect of Direct Antiviral Therapy on Hepatitis c Virus-related Thrombocytopenia
• A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
• Newly Diagnosed Immune Thrombocytopenia Testing the Standard Steroid Treatment Against Combined Steroid & Mycophenolate
• Efficacy and Safety Assessment of a Treatment Combining Rituximab and Belimumab in Adults With Persistent Immune Thrombocytopenia
• Multi-Center Single Arm Trial to Determine The Effectiveness of Warfarin Therapy Duration For Heparin-Induced Thrombocytopenia (HIT)
• TRial to EvaluAte Tranexamic Acid Therapy in Thrombocytopenia
• A Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of ARGX-113 in Patients With ITP
• Clinical Trial of Gut Microbiota in the Management of Immune Thrombocytopenia
• A Single-center Clinical Trial of Bortezomib in Management of Immune Thrombocytopenia (ITP)
• Entospletinib and Obinutuzumab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin Lymphoma
• The PROLONG Trial - Rituximab Maintenance Therapy in ITP
• Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia
• Eltrombopag for the Treatment of Thrombocytopenia Due to Low- and Intermediate Risk Myelodysplastic Syndromes
• Efficacy and Safety of Romiplostim in Adult Subjects With Persistent or Chronic Immune Thrombocytopenia (ITP)
• Evaluating the Pharmacokinetics and Pharmacodynamics of Romiplostim in Patients With Immune Thrombocytopenia (ITP)
• Efficacy of Sialic Acid GNE Related Thrombocytopenia
• DEX Combined With RTX, CSA and IVIG in the Management of Newly Diagnosed ITP Patients
• Rituximab, Eltrombopag and Dexamethasone as Frontline Treatment for Immune Thrombocytopenia
• Immunomodulation With Romiplostim in Young Adults With ITP
• Treatment of ITP With Rituximab and / or Accutane
• Thrombocytopenia in Gestational Period
• Study to Evaluate Safety, Tolerability and Efficacy of UCB7665 in Subjects With Primary Immune Thrombocytopenia
• The Effect of REcombinant Human Thrombopoietin (rhTPO) on Sepsis Patients With aCUte Severe thrombocytopEnia
• Rituximab and Dexamethasone Followed by Mycophenolate Mofetil or Placebo in Patients With Immune Thrombocytopenia
• Different Cycles of High-dose Dexamethasone for Initial Management of Primary Immune Thrombocytopenia (ITP)
• Efficacy and Safety of DAPSone as a Second-line Option in Adult Immune Thrombocytopenia
• American Trial Using Tranexamic Acid in Thrombocytopenia
• PRTX-100-203 Open-Label, Dose Escalation Study in Adult Patients With ITP
• Caffeic Acid Combining High-dose Dexamethasone in Management of ITP
• Aneurysmal Subarachnoid Hemorrhage Trial RandOmizing Heparin
• Prospective Study of Patients With Thrombocytopenia Following HSCT
• Cyclophosphamide and Hydroxychloroquine for Thrombocytopenia in SLE
• Eltrombopag for Inherited Thrombocytopenias
• Eltrombopag in Second Line Adult Primary Immune Thrombosytopenia
• PRTX-100-202 Open-Label, Dose Escalation Study in Adult Patients With ITP
• A Multicenter Study on Recombinant Human Thrombopoietin in Management of ITP in Pregnancy
• Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
• Caffeic Acid Tablets as a Second-line Therapy for ITP
• An Observational Study to Evaluate the Efficacy of Biweekly Romiplostim in Adult Patients With ITP
• VALIDATION OF A PREDICTIVE MODEL OF RESPONSE TO ROMIPLOSTIM IN PATIENTS WITH IPSS LOW OR INTERMEDIATE-1 RISK MDS AND THROMBOCYTOPENIA
• Daily Prednisone Versus Pulsed Dexamethasone in Treatment-naïve Adult Patients With Immune Thrombocytopenia
• A Study of Eltrombopag in Patients With CMML and Thrombocytopenia
• Effect of rhIL-11 in Patients With Thrombocytopenia for Childhood ALL
• Complement Inhibition Using Eculizumab to Overcome Platelet Transfusion Refractoriness in Patients With Severe Thrombocytopenia
• Response Rate and Duration After Discontinuation Thrombopoietin Receptor Agonists Primary Immune Thrombocytopenia
• Long-term Study of Romiplostim in Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP)
• Recombinant Human Thrombopoietin (rhTPO) in Management of Immune Thrombocytopenia (ITP) in Pregnancy
• Efficacy and Safety of rhTPO for the Treatment of Thrombocytopenia After Chemotherapy in AML Patients
• Recombinant Human Thrombopoietin (rhTPO) in Management of Chemotherapy-induced Thrombocytopenia in Acute Myelocytic Leukemia
• Megakaryocytic Progenitor Cells for Prophylaxis and Treatment of Thrombocytopenia
• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Once-daily Oral Avatrombopag in Japanese Subjects With Chronic Liver Diseases and Thrombocytopenia
• Prevention of Thrombocytopenia in Glioblastoma Patients
• A Multicenter Investigation of Recombinant Human Thrombopoietin (rhTPO) Combining Cyclosporin A Versus Cyclosporin A in Management of Steroid-Resistant/Relapsed Immune Thrombocytopenia （ITP）
• A Study of Eltrombopag or Placebo in Combination With Azacitidine in Subjects With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-risk Myelodysplastic Syndromes (MDS)
• An Investigation of Dexamethasone With Different Doses in the Management of Immune Thrombocytopenia (ITP)
• An Investigation of rhTPO With Different Frequencies in the Management of ITP
• A Multicentre Investigation of 2 Cycles Rituximab Compared With Standard Regimen in Management of Steroid-Resistant/Relapsed Immune Thrombocytopenia （ITP）
• A Phase 2 Study to Evaluate the Efficacy and Safety of AMG531 in Aplastic Anemia
• rhTPO in Critical Patients With Thrombocytopenia
• A Study to Assess the Efficacy and Safety of Eltrombopag as a Rescue of Isolated Chemotherapy-induced Thrombocytopenia
• PRevention Of BLeeding in hEmatological Malignancies With Antifibrinolytic (Epsilon Aminocaproic Acid)
• An Open Phase 3 Study of IV-Globulin SN Inj.10% to Treat Immune Thrombocytopenia
• Oral Pacritinib Versus Best Available Therapy to Treat Myelofibrosis With Thrombocytopenia
• Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
• A Five-Treatment-Period Study to Evaluate the Single-Dose Pharmacokinetics and Pharmacodynamics of Avatrombopag in Healthy Japanese and White Subjects
• Using ROMIPLOSTINE for Persistent Thrombocytopenia With Transfusion-dependent Patients Who Received Allogeneic Hematopoietic Stem Cell
• High-dose Dexamethasone Combining Thalidomide Versus Dexamethasone Mono-therapy for Management of Newly-diagnosed ITP
• Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
• Treatment of Thrombocytopenia in Patients With Chronic Liver DiseaseUndergoing an Elective Procedure
• ICON1: Treatment Decisions and Outcomes in Pediatric Refractory ITP
• A Multicenter Randomized Open-label Study of Oseltamivir Combined With HD-DEX Versus HD-DEX in the Management of ITP
• Single Rising Dose Study of MK-8723 in Healthy Participants and Participants With Immune Thrombocytopenia Purpura (MK-8723-001)
• A Rollover Study to Provide Continued Treatment With Eltrombopag
• Study to Reveal if Fibrinogen Treatment Effects Blood Clotting Better Than a Platelet Transfusion
• Bortezomib to Treat Significant Complication of HSCT
• Bortezomib to Treat Significant Complication of HSCT
• All-Trans Retinoic Acid (ATRA) Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)
• Safety and Efficacy of Eltrombopag at Escalated Doses
• Study of Quadruple Therapy With Eltrombopag for Chronic Hepatitis C
• A Pilot Study of N-acetylcysteine in Thrombotic Thrombocytopenia Purpura
• Efficacy and Safety Study of Maintenance Treatment With rhTPO in Thrombocytopenic Subjects With ITP
• Eltrombopag in Patients With Delayed Post Transplant Thrombocytopenia.
• Oxidant Status and Effect of Antioxidant in Immune Thrombocytopenia
• Recombinant Human Thrombopoietin (rhTPO) Combining Rituximab Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)
• Thromboprophylaxis of Venous Thromboembolism in Acutely-ill Medical Inpatients With Thrombocytopenia
• Low-dose Rituximab Regimens in Chinese Adult Patients With Immune Thrombocytopenia
• Efficacy of Rapamycin Therapy With Chronic Immune Thrombocytopenia
• Efficacy of Immunomudulatory Therapy With All-trans Retinoid Acid for Adults With Chronic Immune Thrombocytopenia
• The Combination of ATRA and Danazol as Second-line Treatment in Adult Immune Thrombocytopenia
• A Phase Ⅲa Study of Genetically Modified Recombinant Human Interleukin-11
• Eltrombopag/Boceprevir and Eltrombopag/Telaprevir Drug-Drug Interaction Study In Healthy Adult Subjects
• Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia
• A Trial of Eltrombopag or Intravenous Immune Globulin Before Surgery for Immune Thrombocytopenia Patients
• Eltrombopag for the Treatment of Immune ThrombocytoPenia (ITP) Secondary to Chronic Lymphoproliferative Disorders (LPDs)
• Rivaroxaban for Treatment of Patients With Suspected or Confirmed Heparin-Induced Thrombocytopenia
• Human Placental-Derived Stem Cell Transplantation
• A Multi-center Study of Low-dose Decitabine for the Treatment of Immune Thrombocytopenia
• The Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo and Best Supportive Care in Subjects With Red Blood Cell (RBC) Transfusion-Dependent Anemia and Thrombocytopenia Due to International Prognostic Scoring System (IPS
• Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
• Study of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body.
• Secondary Prophylaxis in Non-Hodgkin Lymphoma (NHL) and Chemotherapy-induced Thrombocytopenia
• Recombinant Human Thrombopoietin in Combination With Rituximab in Immune Thrombocytopenia (ITP)
• Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia
• A Single Arm Pilot Study of Azacitidine in Myelodysplastic Syndromes (MDS) / Acute Myeloid Leukaemia (AML), With Eltrombopag Support for Thrombocytopenia
• Eltrombopag for Thrombocytopenia in Patients With Relapsed Multiple Myeloma
• Safety Study of Eltrombopag Combined With Azacitidine to Treat Myelodysplastic Syndrome (MDS)
• Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients
• A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia
• A Study to Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia.
• Efficacy and Safety of Oral E5501 Plus Standard of Care for the Treatment of Thrombocytopenia in Adults With Chronic Immune Thrombocytopenia (Amendment 02)
• A Phase 3, Multicenter, Randomized, Double-blind,Active-controlled, Parallel-group Trial With an Open-labelExtension Phase to Evaluate the Efficacy and Safety of OralE5501 Versus Eltrombopag, in Adults With Chronic ImmuneThrombocytopenia (Idiopathic
• Eltrombopag Olamine in Treating Thrombocytopenia in Patients With Chronic Myeloid Leukemia or Myelofibrosis Receiving Tyrosine Kinase Therapy
• Eltrombopag in Thrombocytopenic Chronic Lymphocytic Leukemia (CLL) Patients (CLL2S Study of GCLLSG)
• Phase I Study Evaluating TXA127 in Low/Intermediate-1 Risk Myelodysplastic Syndrome and Thrombocytopenia
• Chronic Hepatitis C Virus Related Thrombocytopenia to Evaluate the Effects of E5501
• Efficacy and Safety of Immunoglobulin Intravenous (Human) 10% (NewGam) in Primary Immune Thrombocytopenia
• A Study of the Safety and Efficacy of ONO-7746 in Adult Cancer Patients With Chemotherapy Induced Thrombocytopenia
• Subject Variability in Two Lots of E5501 Administered to Fed and Fasted Healthy Subjects
• Clinical Trial on the Prevention of Thrombocytopenia After First-line Chemotherapy
• Recombinant Human Interleukin-11 Combination Low-dose Rituximab in Immune Thrombocytopenia
• Retrospective Registry of Patients With Acute Heparin-induced Thrombocytopenia Type II
• A Study to Evaluate the Relative Bioavailability and Intra-Subject Variability of Two Lots of E5501 40 mg Tablets Administered Twice as Single Oral Doses to Healthy Subjects
• Eltrombopag in Myelodysplastic Syndrome (MDS) Patients With Thrombocytopenia
• Indirect Comparison Between Eltrombopag & Romiplostim
• Meta-analysis - Eltrombopag
• The Role of Traditional Chinese Medicine in the Treatment of Chronic Childhood Immune Thrombocytopenia (ITP)
• Traditional Chinese Medicine in the Supportive Management of Anaemic and Cytopenic (Leukopenia, Thrombocytopenia) Haematological Disorders
• Study of Eltrombopag in Platelet Refractory Thrombocytopenia
• Phase II Eltrombopag in Chronic Lymphocytic Leukemia (CLL)
• Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic Syndrome
• Romiplostim in Treating Hepatitis C-Infected Patients With Thrombocytopenia
• Safety and Efficacy Study for Solid Tumor Patients Treated With Eltrombopag
• Efficacy of Eltrombopag to Improve Thrombocytopenia of MYH9-related Disease
• An Open-label Safety Study of Lusutrombopag (S-888711) in Adults With Chronic Immune Thrombocytopenia (ITP)
• Milk-only Lactation Study for Patients on Eltrombopag
• A Study to Investigate the Efficacy and Safety of Lusutrombopag (S-888711) Tablets Administered to Adults With Immune Thrombocytopenia (ITP)
• Lenalidomide and Ofatumumab in Treating Participants With Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
• Eltrombopag for Post Transplant Thrombocytopenia
• Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies
• A Pilot Study of a Thrombopoietin-Receptor Agonist, Eltrombopag, in Patients With Low to Int-2 Risk Myelodysplastic Syndrome (MDS)
• A Study to Evaluate Safety and Efficacy of Panobinostat in Participants With Primary Myelofibrosis
• Application of AS101 for the Treatment of Thrombocytopenia in Solid Tumor Patients
• A Pilot Study of the Thrombopoietin-Receptor Agonist Eltrombopag in Refractory Aplastic Anemia Patients
• Once-Daily Oral Avatrombopag Tablets Used in Subjects With Chronic Liver Diseases and Thrombocytopenia Prior to Elective Surgical or Diagnostic Procedures
• Thrombocytopenia and Bleeding in Wiskott-Aldrich Syndrome (WAS) Patients
• Efficacy and Safety Study of Eltrombopag in Pediatric Patients With Thrombocytopenia From Chronic Idiopathic Thrombocytopenic Purpura (ITP)
• Phase I Study of Eltrombopag for Promoting Thrombopoiesis After Total Body Irradiation
• Eltrombopag Treatment of Thrombocytopenia in Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML/MDS)
• Eltrombopag and the Bcl-extra-large (xL) Pathway in Idiopathic Thrombocytopenic Purpura (ITP)
• Study Evaluating The Effects Of Oprelvekin On Cardiac Repolarization In Subjects With Chemotherapy Induced Thrombocytopenia
• Clinical Management of Argatroban in Patients With Heparin Induced Thrombocytopenia Type II
• Drug Interaction Study Between Eltrombopag and Lopinavir/Ritonavir in Healthy Adult Subjects.
• Argatroban Versus Lepirudin in Critically Ill Patients
• A Comparative Sudy Comparing Argatroban® IV vs Desirudin SC for Suspected HIT With or Without Thrombosis Syndrome
• Interleukin-2 Treatment for Wiskott-Aldrich Syndrome
• Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer
• Bivalirudin PCI Registry in Heparin Induced Thrombocytopenia/Heparin Induced Thrombocytopenia and Thrombosis Syndrome (HIT/HITTS) Patients
• Lenalidomide and Alvocidib in Treating Patients With Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
• Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures
• Fondaparinux for the Treatment of Heparin-Induced Thrombocytopenia (HIT)
• Romiplostim Treatment of Thrombocytopenia in Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
• Fondaparinux in Patients With Acute Heparin-Induced Thrombocytopenia (HIT)
• Treatment of Menorrhagia in Women With Thrombocytopenia Using Platelets or Platelets and Hormones
• Safety and Efficacy Study of Romiplostim (AMG 531) to Treat ITP in Pediatric Subjects
• Aspirin in Patients With Myocardial Infarction and Thrombocytopenia
• Interleukin 11, Thrombocytopenia, Imatinib in Chronic Myelogenous Leukemia (CML) Patients
• The Efficacy and Safety of Alemtuzumab in Auotoimmune Cytopenias
• Evaluating the Safety of Long Term Dosing of Romiplostim (Formerly AMG 531) in Thrombocytopenic Subjects With Myelodysplastic Syndromes (MDS)
• Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Therapy
• A Safety and Efficacy Study to Evaluate AMG 531 Treatment in Subject With Myelodysplastic Syndrome Receiving Revlimid
• Romiplostim (AMG 531) Versus Medical Standard of Care for Immune (Idiopathic) Thrombocytopenic Purpura
• Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC)
• Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With Thrombosis
• Dose Finding Study Of Oral Eltrombopag In Patients With Sarcoma Receiving Adriamycin And Ifosfamide
• Rituximab as Second Line Treatment for ITP
• Determination of Safe and Effective Dose of Romiplostim (AMG 531) in Subjects With Myelodysplastic Syndrome (MDS)Receiving Hypomethylating Agents
• Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in Firs
• Safety Study of AMG 531 in Japanese Subjects With ITP
• Determination of Safe Dose of Romiplostim (AMG 531) in Patients With Myelodysplastic Syndromes (MDS)
• Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders
• Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency Disease
• Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia
• Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-Infection
• A Study to Confirm the Efficacy and Safety of Fludarabine Phosphate Administered in Untreated Chronic Lymphocytic Leukemia Patients With Anemia and/or Thrombocytopenia
• Efficacy and Safety Study of Argatroban to Treat Heparin-Induced Thrombocytopenia
• The HIT-TRAP Trial
• A Trial of Antenatal Treatment of Alloimmune Thrombocytopenia
• SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C
• SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy
• AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Prior to Splenectomy
• AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to Splenectomy
• Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen
• Angiomax in Patients With HIT/HITTS Type II Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG) (CHOOSE)
• Daclizumab to Treat Chronic Immune Thrombocytopenia
• Anticoagulant Therapy With Bivalirudin in the Performance of Percutaneous Coronary Intervention in Patients With Heparin-Induced Thrombocytopenia (AT BAT, First Inning)
• Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia
• Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin
• Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia
• Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia
• Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer
• Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid Cancer
• Phase II Pilot Study of Granulocyte Colony-Stimulating Factor for Inherited Bone Marrow Failure Syndromes
• Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia
• Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia
• SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia
• A Phase I, Open Label Trial to Evaluate the Safety, Tolerance and Biological Effects of SDZ ILE-964 (Recombinant Human Interleukin-3, RhIL-3) in HIV Infected Patients With Cytopenia
• Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine